The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Medication management platform MedAdvisor’s (MDR) telehealth and on-demand home delivery features are now live
  • This home delivery service enables patients to order, pay for, and request delivery of their medications from the MedAdvisor App
  • The company said around 1000 pharmacies are now offering delivery to MedAdvisor app patients
  • In just two weeks, MedAdvisor has had more than 9000 items ordered for delivery
  • On market close, MedAdvisor is up 6.02 per cent and is trading for 44¢ per share

Medication management platform MedAdvisor’s (MDR) telehealth and on-demand home delivery features are now live.

The company said around 1000 pharmacies are now offering delivery to MedAdvisor app patients and, in just two weeks, MedAdvisor has had over 3000 delivery requests and 9000 items ordered for delivery.

This home delivery service enables patients to order, pay for, and request delivery of their medications from the MedAdvisor App

CEO Robert Read said COVID-19 has created unprecedented challenges around the globe.

“In response, MedAdvisor has fast-tracked its development roadmap to launch home delivery and telehealth services to assist patients, pharmacies and doctors through these challenging times,” he said.

“The strong early demand for these new services is extremely encouraging,” he added.

This service was launched to help pharmacies leverage the Federal Government’s recently announced $25 million package to deliver much-needed medications to those at risk in the community.

Malouf Pharmacies Harbourside Pharmacist Michael Inglis says MedAdvisor’s medication delivery has helped him automate and manage the large number of delivery orders he is processing, especially during COVID-19.

“Our workloads have skyrocketed with the demand from COVID-19. Being able to protect our staff by having medication delivered to vulnerable patients keeps people out of our pharmacy while enabling us to still provide a high-level of patient care,” he said.

“The delivery tracking feature is also valuable as it allows the pharmacy and patient to know the status of the delivery in real-time,” he added.

MedAdvisor has a discounted fee for each delivery through Kings (up to a 5-kilometre radius from the pharmacy) to $7.77 during the COVID-19 crisis.

Pharmacies can claim this full amount, meaning it costs the pharmacy nothing to
deliver to an eligible patient, once a month.

The service through Kings went live in Sydney and Melbourne last week.

On market close, MedAdvisor is up 6.02 per cent and is trading for 44¢ per share.

MDR by the numbers
More From The Market Online
advanced mri or ct scan medical diagnosis machine at hospital lab

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Imricor Medical Systems Ltd intends to use the capital raising's funds to support a three-pronged growth…
Abstract visualization of a brain hemorrhage from an MRI perspective, with vivid colors marking the hemorrhagic areas against the brain's grayscale anatomy.

Trial for Alterity’s neurodegenerative drug ATH434 shows reduced disability

An interim trial testing the effects of ATH434 on patients with MSA has yielded positive results…
The Market Online Video

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Recce Pharmaceuticals Ltd has been funded to the tune of US$2M by the US Department of…
AI gen cancer cell

Immutep reports strong response rate from immunotherapies treating carcinomas

Immutep Ltd has reported a slew of positive results from a trial to assess a combination…